After $3 million worth of Kratom is seized, FDA continued to warn of its dangers
In an import warning that has been in effect for many years, the FDA has determined that Kratom and dietary supplements containing this herb are adulterated.
Mithragina, commonly known as Kratom, is a plant that grows as a shrub or small tree. It is native to Thailand, Malaysia, Indonesia, and Papua New Guinea. In recent years, this plant has gained a following due to its alleged pain control effect and its ability to help people quit the use of opioids.

Because kratom acts on opioid receptors in the same way as opioid itself, the Drug Enforcement Administration (DEA) has always considered that this substance has the risk of addiction. This plant is not classified as a controlled drug, but the Anti Drug Administration lists it as a "drug of concern and chemical."
Dr. Judy McMeekin, Deputy Director of Regulatory Affairs at the US Food and Drug Administration, said at a press conference at the US Department of Justice, "This lockdown highlights our commitment to take proactive action when companies sell products containing dangerous ingredients such as Kratom. We will continue to protect consumers from illegal sales of products that do not comply with FDA regulations.”

A 2022 study found that nearly one-third of people in the United States who use Kratom meet the criteria for Kratom use disorders, including tolerance, withdrawal, smoking cessation failure, and craving. In recent years, research has also linked Kratom with liver injury and death, but it has also been recognized that this plant is a safer pain treatment option than opioid drugs. A review published in the Journal of Clinical Pharmacology in 2021 found that compared to traditional opioid drugs, Kratom can alleviate pain, cause mild euphoria, and have a lower risk of adverse effects on the respiratory and nervous systems. However, its use is associated with hepatotoxicity, seizures and death. A 2020 study also found that Kratom users in the United States are generally more likely to abuse drugs than those who use marijuana, alcohol, or cigarettes.
“If it is ever studied to a point that the FDA puts its thumb of approval on it, it will be in a purified form and there will be data that shows its safety, “ Saids Dr. Alan Kaye, a professor of anesthesiology and pharmacology at LSU in Shreveport, Louisiana.
Currently, the US Food and Drug Administration continues to advise people not to take Kratom.
2026-09-28
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA issues new guidelines, accelerating the development of personalized medicine
-
关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
-
Japan Tightens the Rules—Then Loosens Them: A Surprising Shift in Food Additive Policy
-
The End of Hype: Europe’s Bio-stimulant Industry Faces a Science-First Reckoning by 2030
-
U.S. and China Open New High-Level Trade Talks on Tariffs, Critical Minerals and Pharma Investment
-
U.S. Formally Imposes Antidumping and Countervailing Duty Orders on Chinese L-Lysine
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
Recommend Reading
-
UK Opens Formal Review of AkzoNobel–Axalta $25 Billion Merger
-
U.S. Congress Passes Bill Authorizing Tariffs of Up to 100% on Major Buyers of Russian Energy
-
U.S. Delays Mandatory GRAS Notification Proposal, Pushing Food-Additive Overhaul to Year-End
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
3M, DuPont and Honeywell Must Face Firefighters’ PFAS Turnout-Gear Lawsuit
-
Acetonitrile: Properties, Uses, and Safety
-
Sodium Percarbonate: Uses, Benefits, and Safety
-
Business Society: Both Supply and Demand Weak, Costs Hard to Sustain—Bisphenol A Set for Volatile Decline in 2025
-
TBHQ: Uses, Safety, and Health Effects
-
December Cyclohexane Market Operates Weakly, Lacking Momentum for Price Increases